Hopital Kremlin Bicetre

Le Kremlin-Bicêtre 94275

0 studies enrolling now · 3 studies all time

What they study most

Antibody-mediated Rejection, Cushing's Syndrome, Kidney Transplantation

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 — Completed
• Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients — Completed